Vitamin D during pregnancy: why observational studies suggest deficiency and interventional studies show no improvement in clinical outcomes? A narrative review
Journal of Endocrinological Investigation, July 2015
S. N. Karras karraspiros at yahoo.gr , P. Anagnostis, D. Naughton, C. Annweiler, A. Petroczi, D. G. Goulis
1. Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
2. School of Life Sciences, Kingston University, Kingston upon Thames, London, UK
3. Robarts Research Institute, The University of Western Ontario, London, ON, Canada
4. Department of Geriatric Medicine, UPRES EA 4638, University Hospital Angers, Angers, France
A considerable number of studies have examined vitamin D status during pregnancy. Although data from observational studies denote vitamin D hypovitaminosis (deficiency or insufficiency) during pregnancy is associated with a plethora of adverse maternal and neonatal outcomes, data from interventional (supplementation) trials fail to reveal a significant impact on maternal and offspring health. The aim of this narrative review was to critically appraise the methodology of the most representative published randomized controlled trials in an attempt to explain the difference between observational and supplementation results.
We found that this difference could be attributed to a variety of factors, namely:
- (i) study design (lack of a specific outcome in conjunction with timing of supplementation, enrolment of participants with heterogeneous vitamin D status);
- (ii) pitfalls in the interpretation of vitamin D equilibrium (lack of determination of plasma half-life);
- (iii) supplementation regimen (administration of a wide range of regimens, in terms of dose, bolus and form);
- (iv) geographical characteristics (vitamin D needs could vary significantly within a country, particularly in areas with a wide range of latitude gradient);
- (v) adaptations of vitamin D metabolism during pregnancy (vitamin D and calcium equilibrium are changed during pregnancy compared with the non-pregnant state) and
- (vi) supplementation of populations with low baseline 25(OH)D values would likely manifest beneficial effects.
All these parameters should be taken into consideration in the design of future vitamin D supplementation trials.
There is been many positive intervention trials and meta-analyses
The articles in Pregnancy AND Intervention are here:
- 3X reduction in preemie Bronchopulmonary Dysplasia if add tiny amount of Vitamin D – meta-analysis June 2024
- 4,000 IU of daily Vitamin D during pregnancy is good (Mongolia this time) – RCT Oct 2023
- Resulting childhood Asthma cut in half if 4,400 IU Vitamin D daily while pregnant - RCT April 2023
- 6,400 IU of Vitamin D is safe and effective during breastfeeding – RCT Dec, 2020
- Vitamin D during pregnancy – single 200,000 IU similar to daily 5,000 IU – April 2020
- Massive improvement in vaginal microbiome during pregnancy with Vitamin D – March 2019
- Autism risk reduced 2X by prenatal vitamins (Vitamin D or Folic) – Feb 2019
- Fetal bones helped a bit by 1,000 IU of vitamin D – RCT Feb 2019
- Adding 1,000 IU vitamin D while pregnant did not help much (no surprise) – RCT Jan 2019
- Pregnancies helped a lot by Vitamin D (injection then 50,000 IU monthly) – RCT May 2018
- 430 genes changed when 3,800 IU Vitamin D added in late second trimester – RCT May 2018
- 300,000 IU of Vitamin D is not enough during pregnancy – RCT May 2018
- Preeclampsia risk reduced 7X by 4,000 IU of Vitamin D daily – RCT March 2018
- Risk of infant Asthma cut in half if mother supplemented Vitamin D to get more than 30 ng – RCT Oct 2017
- Gestational diabetes 30 percent less likely if consumed more than 400 IU of vitamin D daily – Oct 2017
- Monthly 120,000 IU Vitamin D plus daily Calcium was great during pregnancies – RCT Sept 2017
- Preterm birth rate reduced by vitamin D – 78 percent if non-white, 39 percent if white – July 2017
- 1,000 IU of Vitamin D while pregnant helped a little bit (4,000 IU helps a lot) – RCT Dec 2016
- Preeclampsia recurrence reduced 2 X by 50,000 IU of vitamin D every two weeks – RCT July 2017
- Only a select group of women will get a modest benefit from 800 IU of vitamin D – Jan 2017
- Reduction of infant asthma may require good vitamin D when lung development starts (4 weeks) – March 2017
- Gestational diabetes treated by Vitamin D plus Omega-3 – RCT Feb 2017
- 3,800 IU Vitamin D during pregnancy did not help much – RCT Jan 2017
- 50,000 IU of vitamin D for 8 weeks of pregnancy raised most above 30 nanograms - RCT Jan 2017
- Gestational Diabetes reduce 3 times by 5,000 IU of Vitamin D – RCT Jan 2016
- Preeclampsia risk reduced by higher levels of vitamin D (VDAART 4,400 IU) - RCT Nov 2016
- Gestational Diabetes treated with 50,000 IU every two weeks – RCT Sept 2016
- Perinatal depression decreased 40 percent with just a few weeks of 2,000 IU of vitamin D – RCT Aug 2016
- Pregnancy – adding 35,000 IU Vitamin D weekly was nice, but not enough – RCT April 2016
- Vitamin D once during pregnancy reduced infant health care costs (300 times ROI) – RCT Dec 2015
- Autism rate in siblings reduced 4X by vitamin D: 5,000 IU during pregnancy, 1,000 IU to infants – Feb 2016
- Preterm birth rate reduced 57 percent by Vitamin D – Nov 2015
- Pregnancy supplemented with 2,000 IU vitamin D got most infants to more than 12 nanograms – Aug 2015
- Preeclampsia reduced by Vitamin D (50,000 IU bi-weekly) and Calcium – Oct 2015
- Clinical trials for pregnancy with Vitamin D intervention – 51 as of Sept 2015
- No multiple sclerosis relapses during pregnancy if 50,000 IU of Vitamin D weekly – RCT April 2015
- Wheezing reduced 35 percent if vitamin D added during pregnancy – April 2015
- 4,000 IU raised vitamin D levels during pregnancy – July 2014
- Pregnant mothers in Quatar needed more than weekly 50,000 IU Vitamin D – Nov 2013
- Gestational diabetes – Vitamin D and Calcium provided huge benefits – RCT March 2015
- Pregnancy helped by single dose of 60,000 IU of Vitamin D – RCT March 2015
- Gestational diabetes reduced by just two 50,000 IU doses of vitamin D – RCT Nov 2014
- Improved births with 2,000 IU vitamin D during pregnancy in India - RCT Feb 2015
- 50,000 IU of Vitamin D every 2 weeks reduced gestational diabetes – RCT Feb 2015
- Infant much healthier if Gestational Diabetic mother got 2 doses of vitamin D – RCT Nov 2014
- 2000 IU vitamin D during pregnancy and 800 IU to infant resulted in less use of antibiotics – RCT April 2014
- Gestational Diabetes reduced with 50,000 IU of vitamin D every 3 weeks and daily Calcium – RCT June 2014
- Gestational Diabetes reduced 40 percent by 5,000 IU of vitamin D – RCT April 2014
- 5,000 IU Vitamin D was not enough to reduce preeclampsia but did help future infant – RCT April 2014
- Breast milk resulted in 20 ng of vitamin D for infant if mother had taken 5,000 IU daily – RCT Dec 2013
The articles in Pregnancy AND Meta-analysis are here:
- Pregnancy and offspring health - umbrella of 250,000 pregnancies - meta-analysis May 2024
- Vitamin D reduces: pre-eclampia 1.6 X, postpartum dep. 3.6 X, autism 1.5X etc. - meta-analysis March 2024
- Vitamin D supplementation decreased the risk of preeclampsia by 39% – meta-analysis Feb 2024
- Yet another reason to take Vitamin D while pregnant – fight COVID - meta-analysis May 2023
- Vitamin D during pregnancy increased child’s bone mineral density – meta-analysis April 2023
- Preeclampsia reduced by 33 percent if high vitamin D – meta-analysis Feb 2023
- Maternal pregnancy problems if Vitamin D is less than 40 ng – meta-analysis Oct 2022
- Worse COVID during 3Q pregnancy if 2.5 ng lower Vitamin D – meta-analysis Sept 2022
- Miscarriage 1.6 X more likely if low vitamin D – meta-analysis May 2022
- Recurrent Miscarriage 4X more likely if low vitamin D – meta-analysis June 2022
- Pregnancy problems (LBW, PTB, SGA) associated with low vitamin D, 42nd meta-analysis – March 2022
- Low Vitamin D associated with preeclampsia - meta-analysis Feb 2022
- Low Vitamin D associated with pre-eclampsia -40th meta-analysis – Feb 2022
- Small vitamin D doses while pregnant do not decrease infant allergies – meta-analysis Feb 2022
- Anemia 1.6 X more likely during pregnancy if low Vitamin D – meta-analysis Dec 2021
- Vitamin D reduces preeclampsia, gestational diabetes and hypertension - 38th meta-analysis Dec 2021
- Need at least 6,000 IU daily while breastfeeding to eliminate Vitamin D deficiency – meta-analysis Oct 2021
- Gestational diabetes risk reduced 1.5X by Vitamin D – meta-analysis March 2021
- Gestational Diabetes – increased risk if poor Vitamin D Receptor – 2 Meta-Analyses 2021
- Small vitamin D doses given during pregnancy do not reduce childhood asthma – meta-analysis Dec 2020
- Multiple Sclerosis 40 percent more likely if mother had low vitamin D – meta-analysis Jan 2020
- Pregnancies helped by Vitamin D (insulin and birth weight in this case) – meta-analysis Oct 2019
- Preeclampsia 2.7 X less likely if 50,000 IU of Vitamin D every 2 weeks – meta-analysis Sept 2019
- Autism risk increased 30 percent by Cesareans (both low vitamin D) – meta-analysis Sept 2019
- Vitamin D treats Gestational Diabetes, decreases hospitalization and newborn complications – meta-analysis March 2019
- Birth size and weight increased by Vitamin D – meta-analysis Feb 2019
- Pregnancies helped by Vitamin D in many ways – 27th meta-analysis Jan 2019
- Vitamin D supplementation reduced SGA, fetal mortality, infant mortality – JAMA Meta – May 2018
- Gestational Diabetes 39 percent more likely if insufficient Vitamin D – Meta-analysis March 2018
- Preeclampsia reduced 2X by Vitamin D, by 5X if also add Calcium – meta-analysis Oct 2017
- Preeclampsia risk reduced 60 percent if supplement with Vitamin D (they ignored dose size) – meta-analysis Sept 2017
- Small for gestational age is 1.6 X more likely if mother was vitamin D deficient – meta-analysis Aug 2017
- Miscarriage 2 times more likely if low vitamin D – meta-analysis May 2017
- Fewer than half of pregnancies will get even 20 ng of vitamin D with 800 IU daily dose – meta-analysis May 2017
- Low Vitamin D results in adverse pregnancy and birth outcomes – Wagner meta-analysis March 2017
- Bacterial vaginosis in pregnancy increased prematurity risk by 60 percent - meta-analysis 1999
- Preterm birth rate reduced by 43 percent with adequate Vitamin D supplementation – meta-analysis Feb 2017
- Vitamin D during pregnancy reduces risk of childhood asthma by 13 percent – meta-analysis Dec 2016
- Vitamin D helps during pregnancy – meta-analysis Feb 2016
- Preterm birth 30 percent more likely if low vitamin D – meta-analysis May 2016
- Preterm birth extended by 2 weeks with Omega-3 – Meta-analysis Nov 2015
- Gestational Diabetes Mellitus 1.5X more likely if low vitamin D – meta-analysis Oct 2015
- Infant wheezing 40 percent less likely if mother supplemented with vitamin D, vitamin E, or Zinc – meta-analysis Aug 2015
- Birth weight and length increased with high levels of vitamin D – meta-analysis March 2015
- Pregnancy and Vitamin D – meta-analysis April 2015
- More vitamin D needed during pregnancy – meta-analysis Oct 2014
- Preeclampsia rate cut in half by high level of vitamin D – meta-analysis March 2014
- Preeclampsia 2.7X more frequent if low vitamin D – meta-analysis Sept 2013
- 2X more preeclampsia when vitamin D less than 30 ng, etc. - meta-analysis March 2013
- 2X more likely to have preeclampsia if less than 20 ng of vitamin D – Meta-analysis Jan 2013
Overview Pregnancy and vitamin D has the following summary
IU | Cumulative Benefit | Blood level | Cofactors | Calcium | $*/month |
200 | Better bones for mom with 600 mg of Calcium | 6 ng/ml increase | Not needed | No effect | $0.10 |
400 | Less Rickets (but not zero with 400 IU) 3X less adolescent Schizophrenia Fewer child seizures | 20-30 ng/ml | Not needed | No effect | $0.20 |
2000 | 2X More likely to get pregnant naturally/IVF 2X Fewer dental problems with pregnancy 8X less diabetes 4X fewer C-sections (>37 ng) 4X less preeclampsia (40 ng vs 10 ng) 5X less child asthma 2X fewer language problems age 5 | 42 ng/ml | Desirable | < 750 mg | $1 |
4000 | 2X fewer pregnancy complications 2X fewer pre-term births | 49 ng/ml | Should have cofactors | < 750 mg | $3 |
6000 | Probable: larger benefits for above items Just enough D for breastfed infant More maternal and infant weight | Should have cofactors | < 750 mg | $4 |
References
- 1.Lukaszewski MA, Eberlé D, Vieau D, Breton C (2013) Nutritional manipulations in the perinatal period program adipose tissue in offspring. Am J Physiol Endocrinol Metab 305:E1195–E1207PubMedView Article
- 2.Drever N, Saade GR, Bytautiene E (2010) Fetal programming: early-life modulations that affect adult outcomes. Curr Allergy Asthma Rep 10:453–459PubMedView Article
- 3.Poston L (2007) Influences of maternal nutritional status on vascular function in the offspring. Curr Drug Targets 8:914–922PubMedView Article
- 4.Kulkarni B, Hills AP, Byrne NM (2014) Nutritional influences over the life course on lean body mass of individuals in developing countries. Nutr Rev 72:190–204PubMedView Article
- 5.Berti C, Cetin I, Agostoni C, et al. (2014) Pregnancy and infants’ outcome: nutritional and metabolic implications. Crit Rev Food Sci Nutr
- 6.Karras SN, Anagnostis P, Bili E et al (2014) Maternal vitamin D status in pregnancy and offspring bone development: the unmet needs of vitamin D era. Osteoporos Int 25:795–805PubMedView Article
- 7.Kovacs CS (2008) Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr 88:520S–528SPubMed
- 8.Bodnar LM, Simhan HN (2010) Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv 65(4):273–284PubMed CentralPubMedView Article
- 9.Looker AC (2008) Pfeifer Serum 25-hydroxyvitamin D status of the US population. Am J Clin Nutr 88(6):1519–1527PubMed CentralPubMedView Article
- 10.Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF (2009) Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab 94(3):940–945PubMed CentralPubMedView Article
- 11.Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM (2007) Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 92(9):3517–3522PubMed CentralPubMedView Article
- 12.Bodnar LM, Catov JM, Zmuda JM, Cooper ME, Parrott MS, Roberts JM, Marazita ML, Simhan HN (2010) Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr 140(5):999–1006PubMed CentralPubMedView Article
- 13.Zhang C, Qiu C, Hu FB et al (2008) Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE 3:e3753PubMed CentralPubMedView Article
- 14.Lacroix M, Battista MC, Doyon M et al (2014) Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus. Acta Diabetol 51:609–616PubMedView Article
- 15.Zuhur SS, Erol RS, Kuzu I, Altuntas Y (2013) The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency. Clinics (Sao Paulo) 68:658–664View Article
- 16.Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M, Rabi DM (2013) Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. Br Med J 346:f1169View Article
- 17.Haugen M, Brantsaeter AL, Alexander J, Meltzer HM (2008) Dietary supplements contribute substantially to the total nutrient intake in pregnant Norwegian women. Ann Nutr Metab 52:272–280PubMed CentralPubMedView Article
- 18.Hyppönen E, Cavadino A, Williams D et al (2013) Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis. Ann Nutr Metab 63:331–340 PubMedView Article
- 19.Marya RK, Rathee S, Manrow M (1987) Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol Obstet Invest 24:38–42 PubMedView Article
- 20.Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL (2011) Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 26:2341–2357PubMed CentralPubMedView Article
- 21.Baker AM, Haeri S, Camargo C, Stuebe AM, Boggess KA (2012) First trimester maternal vitamin D status and risk for gestational diabetes mellitus: a nested case-control study. Diabetes Metab Res Rev 28:164–168PubMed CentralPubMedView Article
- 22.Hossain N, Kanani FH, Ramzan S, Kausar R, Ayaz S, Khanani R, Pal L (2014) Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open label randomized controlled trial of antenatal vitamin D supplementation in Pakistani women. J Clin Endocrinol Metab 99:2448–2455PubMedView Article
- 23.Yap C, Cheung NW, Gunton JE et al (2014) Vitamin D supplementation and the effects on glucose metabolism during pregnancy: a randomized controlled trial. Diabetes Care 37:1837–1844PubMedView Article
- 24.Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R (2014) Vitamin D and parathyroid hormone status in pregnancy: effect on insulin sensitivity, β-cell function, and gestational diabetes mellitus. J Clin Endocrinol Metab 99(12):4506–4513PubMedView Article
- 25.Yu C, Newton L, Robinson S, Teoh TG, Sethi M (2009) Vitamin D deficiency and supplementation during pregnancy. Clin Endocrinol (Oxf) 70:685–690View Article
- 26.Marya RK, Rathee S, Dua V, Sangwan K (1988) Effect of vitamin D supplementation during pregnancy on foetal growth. Indian J Med Res 88:488–492PubMed
- 27.Brooke OG, Brown IR, Bone CD et al (1980) Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J 280(6216):751–754PubMed CentralPubMedView Article
- 28.Delvin EE, Salle BL, Glorieux FH, Adeleine P, David LS (1986) Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr 109:328–334PubMedView Article
- 29.Mallet E, Gügi B, Brunelle P, Hénocq A, Basuyau JP, Lemeur H (1986) Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet Gynecol 68:300–304PubMedView Article
- 30.Roth DE, Perumal N, Al Mahmud A, Baqui AH (2013) Maternal vitamin D3 supplementation during the third trimester of pregnancy: effects on infant growth in a longitudinal follow-up study in Bangladesh. J Pediatr 163:1605–1611PubMedView Article
- 31.Hypponen E, Sovio U, Wjst M et al (2004) Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci 1037:84–95PubMedView Article
- 32.Goldring ST, Griffiths CJ, Martineau AR et al (2013) Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS ONE 8:e66627PubMed CentralPubMedView Article
- 33.Weyland PG, Grant WB, Howie-Esquivel J (2014) Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill’s criteria for causality. Nutrients 6:3403–3430PubMed CentralPubMedView Article
- 34.Heaney RP (2014) Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 72:48–54PubMedView Article
- 35.Gray RW, Weber HP, Dominguez JH, Lemann J Jr (1974) The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans. J Clin Endocrinol Metab 39:1045–1056PubMedView Article
- 36.Smith JE, Goodman DS (1971) The turnover and transport of vitamin, D and a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest 50:2159–2167PubMed CentralPubMedView Article
- 37.Heaney RP, Armas LA (2015) Quantifying the vitamin D economy. Nutr Rev 73(1):51–67PubMedView Article
- 38.Jones KS, Assar S, Vanderschueren D, Bouillon R, Prentice A, Schoenmakers I (2015) Predictors of 25(OH)D half life and plasma 25(OH)D concentration in the Gambia and the UK. Osteoporos Int 26(3):1137–1146PubMed CentralPubMedView Article
- 39.Hollis BW, Wagner CL (2013) Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98:4619–4628PubMed CentralPubMedView Article
- 40.Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288–294PubMed
- 41.Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204–210PubMed
- 42.Wagner CL, Baggerly C, McDonnell SL, Baggerly L, Hamilton SA, Winkler J, Warner G, Rodriguez C, Shary JR, Smith PG, Hollis BW (2015) Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery. J Steroid Biochem Mol Biol 148:256–260PubMedView Article
- 43.Holick M (2014) Sunlight, ultraviolet-radiation, vitamin D and skin cancer. How much sunlight do we need? In: Reichrath J (ed) Sunlight, Vitamin D and Skin Cancer, 2nd edn. Landes Bioscience and Springer Science, New York, pp 1–16
- 44.Armas LA, Hollis BW, Heaney RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89(11):5387–5391PubMedView Article
- 45.Tripkovic L, Lambert H, Hart K et al (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95:1357–1364PubMed CentralPubMedView Article
- 46.Heaney RP, Recker RR, Grote J et al (2011) Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab 96(3):E447–E452. doi:10.1210/jc.2010-2230 PubMedView Article
- 47.Tjellesen L, Hummer L, Christiansen C et al (1986) Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1(5):407–413PubMed
- 48.Binkley N, Gemar D, Engelke J et al (2011) Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 96(4):981–988PubMed CentralPubMedView Article
- 49.Karras SN, Anagnostis P, Annweiler C et al (2014) Maternal vitamin D status during pregnancy: the Mediterranean reality. Eur J Clin Nutr 68:864–869PubMedView Article
- 50.Xiang F et al (2013) High prevalence of vitamin D insufficiency in pregnant women working indoors and residing in Guiyang, China. J Endocrinol Investig 36:503–507
- 51.Prentice A, Schoenmakers I, Jones KS, Jarjou LM, Goldberg GR (2009) Vitamin D deficiency and its health consequences in Africa. Clin Rev Bone Miner Metab 7:94–106PubMed CentralPubMedView Article
- 52.Kaushal M, Magon N (2013) Vitamin D in pregnancy: a metabolic outlook. Indian J Endocrinol Metab 17:76–82PubMed CentralPubMedView Article
- 53.Kimlin MG, Olds WJ, Moore MR (2007) Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J Photochem Photobiol, B 86:234–239View Article
- 54.Van der Meer IM, Middelkoop BJ, Boeke AJ, Lips P (2011) Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: an overview. Osteoporos Int 22:1009–1021PubMed CentralPubMedView Article
- 55.Karras SN, Anagnostis P, Paschou SA, Kandaraki E, Goulis DG. Vitamin D status during pregnancy: time for a more unified approach beyond borders? Eur J Clin Nutr. 2015
- 56.O’Brien KO, Donangelo CM, Ritchie LD, Gildengorin G, Abrams S, King JC (2012) Serum 1,25-dihydroxyvitamin D and calcium intake affect rates of bone calcium deposition during pregnancy and the early postpartum period. Am J Clin Nutr 96(1):64–72PubMed CentralPubMedView Article
- 57.Thota C, Menon R, Fortunato SJ, Brou L, Lee JE, Al-Hendy A (2014) 1,25-Dihydroxyvitamin D deficiency is associated with preterm birth in African American and Caucasian women. Reprod Sci 21(2):244–250PubMed CentralPubMedView Article
- 58.Ardawi MS, Nasrat HA, BA’Aqueel HS (1997) Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 137:402–409PubMedView Article
- 59.Rousseau AF, Damas P, Janssens M et al (2014) Critical care and vitamin D status assessment: what about immunoassays and calculated free 25OH-D? Clin Chim Acta 437:43–47PubMedView Article
- 60.Powe CE, Evans MK, Wenger J et al (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369:1991–2000PubMed CentralPubMedView Article
- 61.Hollis BW, Bikle DD (2014) Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med 370(9):879–880PubMed CentralPubMed
- 62.Aslani S, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Afshar AN, Karimi F (2011) VDR FokI polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications. Gynecol Endocrinol 27:1055–1060PubMedView Article
- 63.Karras SN, Shah I, Petroczi A et al (2013) An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms. Nutr J 12:77PubMed CentralPubMedView Article
- 64.Shah I, Petroczi A, Tabet N, Klugman A, Isaac M, Naughton DP (2012) Low 25OH vitamin D2 levels found in untreated Alzheimer’s patients, compared to acetylcholinesterase-inhibitor treated and controls. Curr Alzheimer Res 9:1069–1076PubMedView Article
- 65.Shah I, James R, Barker J, Petroczi A, Naughton DP (2011) Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J 10:46PubMed CentralPubMedView Article
- 66.Shah I, Petroczi A, Naughton DP (2012) Method for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometry. Chem Central J 6:112View Article
- 67.Shah I, Petroczi A, Naughton DP (2014) Exploring the role of vitamin D in type 1 diabetes, rheumatoid arthritis and Alzheimer’s disease: new insights from accurate analysis of ten forms. J Clin Endocrinol Metab 99:808–816PubMedView Article
- 68.Naughton DP, Petroczi A (2014) Vitamin D status and ill health. Lancet Diabetes Endocrinol 2:274–275PubMedView Article
- 69.Karras SN, Petroczi A, Anagnostis P, Naughton DP (2015) Vitamin D epimer: a significant bio regulator or an inactive compound?. Osteoporos Int
- 70.Cannell JJ, Grant WB, Holick MF. Vitamin D and inflammation. Dermatoendocrinol. 2014; 6(1):e983401-1-10
Publisher wants $40 for the PDF
5752 visitors, last modified 28 Jul, 2015, |